Elevated serum vascular endothelial growth factor and development of cardiac allograft vasculopathy in children

The increase in serum VEGF before onset of detectable CAV is fundamental to its utility as a predictive biomarker and suggests further investigations of VEGF in the pathogenesis of CAV are warranted in the pediatric heart transplant population.